comparemela.com

Latest Breaking News On - Philip bejon - Page 1 : comparemela.com

Alarming safety, ethical, and efficacy concerns surround WHO authorization of first malaria vaccine RTS,S -- Health & Wellness -- Sott net

Plasmodium parasites are as stealthy as pathogens come. The malaria-causing single-celled organisms have been adapting to the human lineage for longer than our species has existed, giving them millions of years of training in evading our immune.

Hope, Concern Surround WHO Green Light of First Malaria Vaccine

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021 | Global Health | JAMA

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021 | Global Health | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

A health economist confronts Kenya s pandemic

In 2007, Kenyan health economist Edwine Barasa had a long layover at Heathrow Airport. A fervent supporter of the London-based soccer club Arsenal, he saw a chance to fulfill a lifelong dream: visiting the club s ancestral stadium in Highbury. Even though he didn t have the right paperwork, he managed to convince an immigration officer to stamp his passport with a warning that he absolutely had to be back in 12 hours or they would both be in trouble. The incident speaks to Barasa s tenacity and powers of persuasion, says his boss, Philip Bejon, who directs the Kenya Medical Research Institute (KEMRI)–Wellcome Trust Research Programme. These traits, Bejon says, have served Barasa well in his role as director of the program s office in Nairobi, where he s been a key player in Kenya s response to the COVID-19 pandemic. “Edwine always shows up as an authentic and sincere scientist who convinces his colleagues.”

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.